| 000 -LEADER |
|---|
| fixed length control field |
00876nam a22001937a 4500 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
GY-GeU |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20140204150543.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
140204b xxu||||| |||| 00| 0 eng d |
| 040 ## - CATALOGING SOURCE |
|---|
| Transcribing agency |
UG |
| 100 ## - MAIN ENTRY--PERSONAL NAME |
|---|
| Personal name |
Sosolik C. Randolph. |
| 245 ## - TITLE STATEMENT |
|---|
| Title |
Immunopathology |
| Statement of responsibility, etc |
Randolph C. Sosolik, Charles L. Hitchcock, William J. Becker |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
|---|
| Place of publication, distribution, etc |
Columbus, Ohio : |
| Name of publisher, distributor, etc |
The Ohio State of University Medical Center |
| Date of publication, distribution, etc |
October 1996. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
506-510 p. |
| 490 ## - SERIES STATEMENT |
|---|
| Series statement |
American Journal of Clinical Pathology |
| Volume number/sequential designation |
Vol. 107 |
| 500 ## - GENERAL NOTE |
|---|
| General note |
Dual - site murine antibody - based immunoassays are commonly used in clinical laboratories to quantitate the MB isoenzyme of creatine kinase (CK -MB). Because the serum level of CK - MB is a relatively specific and sensitive indicator of myocardial diagnosis........ |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc |
Bibliography : 510 p. |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Immunopathology |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
|